The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), the widely-used drugs Procrit, Epogen and Aranesp for the treatment of anemia.
According to the warning the widely used drugs can increase the risk of death and other serious problems in [...]

Today the FDA issued a serious public health advisory for three drugs used to treat various anemia conditions by stimulating red blood cell production (called ESAs).
A new study published in The New England Journal of Medicine found a higher chance of the combination of death, heart attack, hospitalizations for heart failure and stroke in certain [...]